Voyager Therapeutics stock jumps on 2nd Parkinson's deal
February 22, 2019 at 11:31 AM EST
Voyager (Nasdaq: VYGR) is expanding its partnership with pharmaceutical company AbbVie (Nasdaq: ABBV), launching a research effort to develop antibody treatments that can be delivered directly to the brain and target a protein called alpha-synuclein.
